Date Modified

2019-03-03

Period

12/months

Report Summary

This observational study has assessed the effects of Omega 3 fatty acid in steatosis and stiffnesss of NAFLD patients. We evaluated 100 NAFLD patients coming to Hepatology department, BSMMU with nonspecific symptoms with USG findings of fatty liver, by anthropometric features, biochemical test, and finally Fibroscan with CAP. These patients were divided in 2 groups, finally 50 patients were treated with Omega 3 fatty acid and 50 patients received no drug. In this study 6 months therapy with Omega 3 fatty acid has improved the steatosis and ALT but not stiffness, AST, GGT, waist circumference, lipid profile and BMI irrespective of diabetic status. In summary, this study demonstrate that Omega 3 fatty acid may improve steatosis and ALT but not stiffness in NAFLD patients. Side effects of the drug are negligible.

Attached file